NYRNISSE Trademark

Trademark Overview


On Thursday, December 13, 2018, a trademark application was filed for NYRNISSE with the United States Patent and Trademark Office. The USPTO has given the NYRNISSE trademark a serial number of 79249995. The federal status of this trademark filing is CANCELLED - SECTION 71 as of Friday, February 13, 2026. This trademark is owned by NOVARTIS AG. The NYRNISSE trademark is filed in the Pharmaceutical Products category with the following description:

Anti-infectives; anti-inflammatories; antibacterial pharmaceuticals; antibiotics; antifungal pharmaceutical preparations; antivirals; cardiovascular pharmaceuticals; dermatological pharmaceutical preparations; inhaled pharmaceutical preparations for the prevention and treatment of respiratory diseases and disorders; pharmaceutical preparations acting on the central nervous system; pharmaceutical preparations and substances for the prevention and treatment of gastrointestinal diseases; pharmaceutical preparations for the prevention and treatment of diseases and disorders of the autoimmune system, the metabolic system, the endocrine system, the musculo-skeletal system and the genitourinary system; pharmaceutical preparations for use in hematology and in tissue and organ transplantation; pharmaceutical preparations for the prevention and treatment of eye diseases and conditions; pharmaceutical preparations for the prevention and treatment of heart rhythm disorders; pharmaceutical preparat...
nyrnisse

General Information


Serial Number79249995
Word MarkNYRNISSE
Filing DateThursday, December 13, 2018
Status709 - CANCELLED - SECTION 71
Status DateFriday, February 13, 2026
Registration Number5816205
Registration DateTuesday, July 30, 2019
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, May 14, 2019

Trademark Statements


Goods and ServicesAnti-infectives; anti-inflammatories; antibacterial pharmaceuticals; antibiotics; antifungal pharmaceutical preparations; antivirals; cardiovascular pharmaceuticals; dermatological pharmaceutical preparations; inhaled pharmaceutical preparations for the prevention and treatment of respiratory diseases and disorders; pharmaceutical preparations acting on the central nervous system; pharmaceutical preparations and substances for the prevention and treatment of gastrointestinal diseases; pharmaceutical preparations for the prevention and treatment of diseases and disorders of the autoimmune system, the metabolic system, the endocrine system, the musculo-skeletal system and the genitourinary system; pharmaceutical preparations for use in hematology and in tissue and organ transplantation; pharmaceutical preparations for the prevention and treatment of eye diseases and conditions; pharmaceutical preparations for the prevention and treatment of heart rhythm disorders; pharmaceutical preparations for the prevention and treatment of immune system related diseases and disorders; pharmaceutical preparations for the prevention and treatment of kidney diseases; pharmaceutical preparations for the prevention and treatment of diabetes; pharmaceutical preparations for the prevention and treatment of hypertension; pharmaceutical preparations for the prevention and treatment of skin disorders; pharmaceutical preparations for use in dermatology; pharmaceutical preparations for use in urology; pharmaceutical preparations for ophthalmological use; pharmaceutical preparations for the prevention and treatment of cancer and tumors; pharmaceutical preparations for the prevention and the treatment of allergies; pharmaceutical preparations for the prevention and treatment of bone diseases; pharmaceutical preparations for the prevention and treatment of respiratory diseases and asthma

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status CodeF - NOT AVAILABLE
Class Status DateFriday, February 13, 2026
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameNOVARTIS AG
Party Type30 - Original Registrant
Legal Entity Type25 - NOT AVAILABLE
AddressCH

Party NameNOVARTIS AG
Party Type20 - Owner at Publication
Legal Entity Type25 - NOT AVAILABLE
AddressCH

Party NameNOVARTIS AG
Party Type10 - Original Applicant
Legal Entity Type25 - NOT AVAILABLE
AddressCH

Trademark Events


Event DateEvent Description
Thursday, January 24, 2019SN ASSIGNED FOR SECT 66A APPL FROM IB
Monday, January 28, 2019LIMITATION FROM ORIGINAL APPLICATION ENTERED
Tuesday, January 29, 2019NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Saturday, February 2, 2019APPLICATION FILING RECEIPT MAILED
Tuesday, February 5, 2019ASSIGNED TO EXAMINER
Wednesday, February 6, 2019NON-FINAL ACTION WRITTEN
Thursday, February 7, 2019NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Wednesday, February 20, 2019REFUSAL PROCESSED BY MPU
Wednesday, February 20, 2019NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Friday, March 8, 2019REFUSAL PROCESSED BY IB
Thursday, March 28, 2019TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Thursday, March 28, 2019ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Monday, April 1, 2019TEAS RESPONSE TO OFFICE ACTION RECEIVED
Monday, April 1, 2019CORRESPONDENCE RECEIVED IN LAW OFFICE
Tuesday, April 2, 2019TEAS/EMAIL CORRESPONDENCE ENTERED
Wednesday, April 3, 2019APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, April 24, 2019NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, May 14, 2019PUBLISHED FOR OPPOSITION
Tuesday, May 14, 2019OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, July 30, 2019REGISTERED-PRINCIPAL REGISTER
Wednesday, October 30, 2019FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Thursday, November 21, 2019FINAL DISPOSITION PROCESSED
Thursday, November 21, 2019FINAL DISPOSITION NOTICE SENT TO IB
Friday, December 13, 2019FINAL DECISION TRANSACTION PROCESSED BY IB
Tuesday, July 30, 2024COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED
Friday, February 13, 2026CANCELLED SECTION 71